Detalle Publicación

ARTÍCULO

Minimal macroscopic residual disease (0.1-1 cm). Is It still a surgical goal in advanced ovarian cancer?

Autores: Chiva de Agustín, Luis; Castellanos T,; Alonso S, ; González Martín, Antonio
Título de la revista: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
ISSN: 1048-891X
Volumen: 26
Número: 5
Páginas: 906-11
Fecha de publicación: 2016
Resumen:
Patients with ovarian cancer with MMRD after primary surgery obtain a modest but significant advantage in survival (10 months) over suboptimal patients. Patients with macroscopic residual disease (0.1-0.5 cm) obtain a better survival (53 months) than those with more than 0.5 to 1 cm. We propose that they should be classified as a different prognostic group.
DOI: https://doi.org/10.1097/IGC.0000000000000690.
Impacto:
Google Scholar